CTC Capital Management »

Summit Therapeutics shares owned by CTC Capital Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by CTC Capital Management from 13F filings

Historical chart of CTC Capital Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by CTC Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by CTC Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $18k 10k 1.75

More positions owned by CTC Capital Management

Ishares Tr Iboxx Inv Cp Etf (LQD)
Ferguson SHS (FERG)
Select Sector Spdr Tr Financial (XLF)
Mastercard Incorporated Cl A (MA)
Yamana Gold
Coupang Cl A (CPNG)
Lattice Semiconductor (LSCC)
Cnh Indl N V SHS (CNHI)
Copart (CPRT)
Paccar (PCAR)
Ross Stores (ROST)
NetApp (NTAP)
Te Connectivity SHS (TEL)
Builders FirstSource (BLDR)
S&p Global (SPGI)

View all positions for CTC Capital Management

Top funds holding Summit Therapeutics

Vanguard Group
Charles Schwab Investment Management
Steward Partners Investment Advisory
ALPS Advisors
Barclays
Bank of New York Mellon
Jpmorgan Chase & Co
Swiss National Bank
Goldman Sachs Group
UBS Group
Advisor Group Holdings
China Universal Asset Management
Rhumbline Advisers
CSS
Bank of America Corporation

View all funds holding Summit Therapeutics